Showing results (151-160 of 186) with videos related to
Sort By:
Pageof 19
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 26, 2006
Determinants of vitamin D status in older men living in a subtropical climateM J Bolland, A B Grey, R W Ames, et al.Plos Biology|July 12, 2007
Myc dynamically and preferentially relocates to a transcription factory occupied by IghCameron S Osborne, Lyubomira Chakalova, Jennifer A Mitchell, et al.Nature Immunology|April 27, 2004
Antisense intergenic transcription in V(D)J recombinationDaniel J Bolland, Andrew L Wood, Colette M Johnston, et al.Archives of Internal Medicine|November 13, 2008
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older menIan R Reid, Ruth Ames, Barbara Mason, et al.Journal of Internal Medicine|March 20, 2019
Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trialI R Reid, A M Horne, B Mihov, et al.BMJ (Clinical Research Ed.)|January 17, 2008
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trialMark J Bolland, P Alan Barber, Robert N Doughty, et al.American Journal of Human Genetics|August 2, 2007
Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophyJannine Clapp, Laura M Mitchell, Daniel J Bolland, et al.The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected menMark J Bolland, Andrew Grey, Anne M Horne, et al.Clinical Endocrinology|November 2, 2011
Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)Mark J Bolland, Andrew Grey, Anne M Horne, et al.The Journal of Clinical Endocrinology and Metabolism|October 17, 2025
Anti-fracture efficacy of 5- or 10- yearly zoledronate in women aged 50-60y: secondary analyses of a randomized trialMark J Bolland, Zaynah Nisa, Anna Mellar, et al.Pageof 19